ALSERES PHARMACEUTICALS INC /DE (ALSE) financial statements (2020 and earlier)

Company profile

Business Address 275 GROVE STREET
AUBURNDALE, MA 02466
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments01
Cash and cash equivalents00
Short-term investments01
Restricted cash and investments 0
Prepaid expense and other current assets0
Other undisclosed current assets0 
Total current assets:01
Noncurrent Assets
Property, plant and equipment 0
Deferred costs00
Total noncurrent assets:00
TOTAL ASSETS:01
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:12
Other undisclosed accounts payable and accrued liabilities12
Debt 7
Due to related parties10
Deferred revenue and credits00
Other liabilities00
Other undisclosed current liabilities0 
Total current liabilities:210
Noncurrent Liabilities
Long-term debt and lease obligation8 
Long-term debt, excluding current maturities8 
Liabilities, other than long-term debt11
Deferred revenue and credits11
Other liabilities00
Other undisclosed noncurrent liabilities 16
Total noncurrent liabilities:917
Total liabilities:1127
Stockholders' equity
Stockholders' equity attributable to parent, including:(11)(27)
Common stock00
Additional paid in capital189172
Accumulated other comprehensive income (loss)0(0)
Retained earnings 0
Other undisclosed stockholders' equity attributable to parent(200)(199)
Other undisclosed stockholders' equity00
Total stockholders' equity:(10)(26)
TOTAL LIABILITIES AND EQUITY:01

Income statement (P&L) ($ in millions)

12/31/2013
12/31/2012
Gross profit:01
Operating expenses(1)(2)
Operating loss:(1)(1)
Nonoperating income10
Investment income, nonoperating00
Other nonoperating income00
Interest and debt expense(0)(0)
Net income (loss):0(2)
Other undisclosed net loss attributable to parent(1) 
Net loss available to common stockholders, diluted:(1)(2)

Comprehensive Income ($ in millions)

12/31/2013
12/31/2012
Net income (loss):0(2)
Comprehensive income (loss):0(2)
Other undisclosed comprehensive loss, net of tax, attributable to parent(1) 
Comprehensive loss, net of tax, attributable to parent:(1)(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: